Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence

BACKGROUND: Antithrombotic medications (anticoagulants and antiplatelets) are often withheld in the periprocedural period and after bleeding complications to limit the risk of new or recurrent bleeding. These medications are also stopped by patients for various reasons such as cost, side effects, or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Broderick, Joseph P., Bonomo, Jordan B., Kissela, Brett M., Khoury, Jane C., Moomaw, Charles J., Alwell, Kathleen, Woo, Daniel, Flaherty, Matthew L., Khatri, Pooja, Adeoye, Opeolu, Ferioli, Simona, Kleindorfer, Dawn O.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166233/
https://ncbi.nlm.nih.gov/pubmed/21719769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.110.611905
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares